Document Detail

Evaluation of functional relationship between mouse hippocampal cholinergic and nitrergic systems in anxiogenic-like behavior.
MedLine Citation:
PMID:  23625379     Owner:  NLM     Status:  Publisher    
Although a body of evidence shows the crucial role of hippocampal nitrergic and cholinergic systems in the modulation of anxiety, little is known about their functional relationship with regard to anxiety. The present study investigated the relationship between intra-CA1 administration of a nicotinic acetylcholine receptor antagonist (mecamylamine) and a nitric oxide synthase inhibitor [Nω-nitro-L-arginine methyl ester (L-NAME)] or its precursor (L-arginine) in anxiety-related behaviors. Mice received bilateral intra-CA1 injections of either L-NAME or L-arginine in the presence of mecamylamine and were subsequently tested in the elevated plus maze. A dose of 0.5 μg/0.5 μl mecamylamine bilaterally administered into CA1 did not change the percentage of open arm time (%OAT) or the percentage of open arm entries (%OAE) in the elevated plus maze task and thus was considered as a subeffective dose. Intra-CA1 administration of either L-arginine (1 and 1.5 μg/0.5 μl, bilaterally) or L-NAME (at 60 ng/0.5 μl, bilaterally) decreased %OAT, which represents an anxiogenic-like effect. Coadministration of the subeffective dose of mecamylamine together with the lower doses of L-NAME (10 and 30 ng/0.5 μl, bilaterally) or L-arginine (0.5 μg/0.5 μl, bilaterally) led to a decrease in %OAT and %OAE. Thus, both L-NAME and L-arginine showed anxiogenic-like effects, but the effects of mecamylamine were too small to support a functional relationship between the hippocampal cholinergic and nitrergic systems.
Mohammad-Reza Zarrindast; Morteza Piri; Maryam Bananej; Zahra Shahab; Maryam Zahmatkesh
Related Documents :
19397969 - Subchronic toxicity and plasma pharmacokinetic studies on wogonin, a natural flavonoid,...
23474269 - Neutralization of apis mellifera bee venom activities by suramin.
22085489 - Transplacental carcinogenesis with dibenzo[def,p]chrysene (dbc): timing of maternal exp...
9245969 - Tissue distribution and general safety of mndpdp in male beagle dogs, with or without t...
22262939 - Effect of gentiana olivieri on experimental epilepsy models.
22000579 - Toll-like receptor 5 agonist protects mice from dermatitis and oral mucositis caused by...
16188409 - Evaluation of medicinal plants from mali for their in vitro and in vivo trypanocidal ac...
23672519 - Advanced nasopharyngeal carcinoma radiotherapy with volumetric modulated arcs and the p...
16174679 - Establishing a dose-response relationship for oral risperidone in relapsed schizophrenia.
Publication Detail:
Journal Detail:
Title:  Behavioural pharmacology     Volume:  24     ISSN:  1473-5849     ISO Abbreviation:  Behav Pharmacol     Publication Date:  2013 Jun 
Date Detail:
Created Date:  2013-4-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9013016     Medline TA:  Behav Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  229-236     Citation Subset:  -    
aDepartment of Neuroscience, School of Advanced Technologies in Medicine bDepartment of Pharmacology, School of Medicine cIranian National Center for Addiction Studies, Tehran University of Medical Sciences dSchool of Cognitive Sciences, Institute for Research in Fundamental Sciences (IPM) eInstitute of Cognitive Science Studies (ICSS) fDepartment of Biology, Islamic Azad University, Tehran North branch, Tehran gDepartment of Biology, Faculty of Basic Sciences, Islamic Azad University, Ardabil branch, Ardabil, Iran.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Noradrenergic neurotransmission within the bed nucleus of the stria terminalis modulates the retenti...
Next Document:  Patients' Experiences Following Local-Regional Recurrence of Thyroid Cancer: A Qualitative Study.